Candida parapsilosis D4 Hartkapseln
Country: Switzerland
Language: German
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
candida parapsilosis e volumine cellulae (lyophil., steril.) D4 (HAB 6)
Available from:
ebi-pharm ag
INN (International Name):
candida parapsilosis e volumine cellulae (lyophil., steril.) D4 (HAB 6)
Pharmaceutical form:
Hartkapseln
Composition:
Zulassung gilt auch für alle höheren Folgepotenzen: candida parapsilosis e volumine cellulae (lyophil., steril.) D4 (HAB 6) 330 mg, lactosum monohydricum 330 mg, Kapselhülle: hypromellosum, pro capsula.
Class:
D
Therapeutic group:
Homöopathische Arzneimittel
Therapeutic area:
Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)
Authorization status:
zugelassen
Authorization date:
2018-12-06
